Effects of krestin (PSK) on tumorigenesis induced by two-stage and complete chemical carcinogenesis.
The effects of PSK on tumorigenesis in mouse skin were investigated either when mouse skins were initiated by benzo(a)pyrene and promoted by 12-O-tetradecanoyl-phorbol-13-acetate (Group I, two-stage carcinogenesis) or when both initiated and promoted by benzo(a)pyrene (Group II, complete carcinogenesis). Twelve mice in each group were fed chow with or without 0.4% PSK. This concentration of PSK was determined by calculation to give mice enough PSK to exert antitumorigenic activity without cytotoxicity. By the end of the experimental periods (26 weeks), two carcinoma-burdened mice in Group I without PSK were dead, but no carcinomas at all were identified in the mice fed with PSK, although considerable numbers of papillomas developed in both groups. In Group II, carcinomas started to evolve at the 15th week of the experiment regardless of PSK feeding. The number of carcinomas observed in the mice fed with PSK in Group II was statistically significantly lower than that in the mice fed without PSK. Histologically, mild inflammatory infiltrations were seen around the papillomas, and moderate to dense infiltrations, mainly composed of neutrophils, T lymphocytes, and macrophages, were observed in squamous cell carcinomas. There were apparently no significant differences in the number of the infiltrating cells around carcinomas in PSK (+) and PSK (-) groups in both early and fully developed lesions. However, considerable numbers of cells infiltrating into the nests were observed in the early lesions of elicited carcinomas in the mice fed with PSK, while such cells were rarely seen in carcinoma nests in the group without PSK at that stage.(ABSTRACT TRUNCATED AT 250 WORDS)
Nakayama
J
J
Department of Dermatology, Faculty of Medicine, Kyushu University, Fukuoka, Japan.
Urabe
A
A
Terao
H
H
Moon
D C
DC
Hori
Y
Y
Kinoshita
N
N
D000276:Adjuvants, Immunologic / Q000494:pharmacology; D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000494:pharmacology*; D001564:Benzo(a)pyrene; D002294:Carcinoma, Squamous Cell / Q000139:chemically induced / Q000276:immunology / Q000473:pathology; D005260:Female; D008264:Macrophages / Q000473:pathology; D051379:Mice; D008815:Mice, Inbred Strains; D009504:Neutrophils / Q000473:pathology; D010212:Papilloma / Q000139:chemically induced / Q000276:immunology / Q000473:pathology; D011509:Proteoglycans / Q000494:pharmacology*; D012867:Skin / Q000473:pathology; D012878:Skin Neoplasms / Q000139:chemically induced* / Q000276:immunology / Q000473:pathology; D013755:Tetradecanoylphorbol Acetate
D000276:Adjuvants, Immunologic; D000903:Antibiotics, Antineoplastic; D011509:Proteoglycans; D001564:Benzo(a)pyrene; C010770:polysaccharide-K; D013755:Tetradecanoylphorbol Acetate